Coverage
-
January 04, 2022
Nimbus Therapeutics LLC agreed Tuesday to drop its case in New York federal court that sought to avoid selling Bristol-Myers Squibb Co. and its subsidiary Celgene Corp. a psoriasis drug the startup is developing.
3 other articles on this case.
View all »